Geng et al. has discovered that several core biomarkers, such as TP53, TOP2A, CDK1, CCNB1, CDC20, CCNA2, NDC80, AURKA, BIRC5, CCNB2, KIF11 and MAD2L1, were associated with the outcome of glioma [8]. This evidence concerns the gene AURKA and central nervous system cancer.